Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment.

Publication/Presentation Date

3-1-2021

Abstract

Valvular heart disease is present in about 1% of pregnancies, and it poses a management challenge as both fetal and maternal lives are at risk of complications. Pregnancy is associated with significant hemodynamic changes, which can compromise the cardiac status in women with underlying valvular disorders. Management of valvular heart diseases has undergone considerable innovation and advancement with newer techniques, approaches and devices being employed. The decision regarding the management of anticoagulation, especially in patients with prosthetic valves, raises distinct questions and challenges. In this review, we describe the management of common valvular heart diseases encountered during pregnancy, role of percutaneous catheter based therapeutic interventions, the importance of a team-based approach, and the challenges given existing gaps in the literature.

Volume

46

Issue

3

First Page

100679

Last Page

100679

ISSN

1535-6280

Disciplines

Cardiology | Obstetrics and Gynecology

PubMedID

32868039

Department(s)

Cardiology Division, Department of Obstetrics and Gynecology

Document Type

Article

Link to Full Text

Share

COinS